Variant report
Variant | esv32877 |
---|---|
Chromosome Location | chr9:116422327-116422643 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548718223 | chr9:116422350-116422351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs114823995 | chr9:116422424-116422425 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10981872 | chr9:116422447-116422448 | Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs139104122 | chr9:116422482-116422483 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545560032 | chr9:116422488-116422489 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547695471 | chr9:116422551-116422552 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568500443 | chr9:116422584-116422585 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10981873 | chr9:116422585-116422586 | Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs531430763 | chr9:116422589-116422590 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140564084 | chr9:116422634-116422635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 19147751 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Bladder cancer | 21909424 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:116420200-116425800 | Weak transcription | Psoas Muscle | Psoas |
2 | chr9:116420400-116425800 | Weak transcription | Left Ventricle | heart |
3 | chr9:116420800-116427200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr9:116421000-116423800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
5 | chr9:116421000-116425800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
6 | chr9:116422200-116426000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
7 | chr9:116422400-116422600 | Bivalent Enhancer | Primary neutrophils fromperipheralblood | blood |